Sparian Biosciences is an early-stage CNS-focused biopharmaceutical company committed to developing novel, transformational therapies. Diseases of the central nervous system represent a major unmet need but recently there has been little innovation and development. Sparian was co-founded by Gavril Pasternak, MD PhD and Jeff Reich, MD to develop therapeutics targeting the brain through innovative science and novel drug discovery.

Currently, we have 4 programs addressing various aspects of the opioid crisis - a crisis in urgent need of innovation. Two of our compounds come from the Pasternak Lab at Memorial Sloan Kettering Cancer Center, one comes from the USC Michelson Center for Convergent Bioscience and one comes from a collaboration with Washington University. Core to our strategy, we have ongoing scientific and clinical collaborations with MSKCC, Washington University, St. Louis College of Pharmacy, Rutgers University Medical School, University of Florida, and the U.S. Department of Defense.

Sparian is based out of BioLabs@NYULangone in NYC, a national biotech incubator, and is a member of the StartupNY program.

Biotechnology

Consulting

Pharmaceutical

Therapeutics

Sparian Biosciences

Sparian Biosciences' headquarters in New York, NY, United States

Description

People (3)

Jeff Reich

Annie Pasternak

Gus Northrop

Jobs